even as it was negotiating a $430 million settlement to resolve prior off-label uses related to its anti-seizure drug Neurontin (gabapentin; Nat. Biotechnol. 26, 867–875, 2008). “Such blatant ...

This off-label drug use report is made possible through collaboration ... claims regarding the marketing of the prescription drug Neurontin (gabapentin).

Gabapentin is a drug commonly used in humans to treat seizures, nerve pain and restless leg syndrome. These applications have ...